核表皮生长因子受体 (nEGFR) 在临床治疗中
Junkan Zhu1, Zhiyao Wu1, Guangyao Shan1
1Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Xuhui District, Shanghai, 200032, China.
核EGFR (nEGFR) 积累,与膜EGFR不同,与预后不佳相关,并影响瘤进展. 准nEGFR转位为癌症治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 皮表皮生长因子受体 (EGFR) 是癌症治疗的关键标,目前的治疗重点是膜结合受体.
- 胚胎外EGFR在细胞核中的积累 (nEGFR) 与瘤进展和患者表现不佳有关.
- nEGFR作为转录调节剂和激酶,影响DNA修复,细胞循环和治疗耐药性.
研究的目的:
- 审查nEGFR表达和临床结果之间的关联.
- 阐明nEGFR的核心功能和调节作用.
- 总结EGFR核转移的机制,并确定潜在的治疗点.
主要方法:
- 文献综述侧重于nEGFR表达,功能和转位.
- 对调查nEGFR.的临床意义的研究分析.
- 综合目前对EGFR核进出口通道的理解.
主要成果:
- nEGFR表达与各种癌症的不良临床结果有关.
- nEGFR调节基因表达,并影响DNA修复和增殖等关键细胞过程.
- 核进口EGFR涉及复杂的内部化,贩运和核信封穿机制.
结论:
- 由于其核定位,nEGFR代表了一个重要的,但具有挑战性的治疗目标.
- 了解EGFR核转移中的分子参与者对于开发新的抗癌策略至关重要.
- 准nEGFR转位通路为创新的癌症疗法提供了一个有希望的途径.
更多相关视频
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
相关概念视频
Mitogens and the Cell Cycle
Clinical Applications of Epidermal Stem Cells
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
